Findings Conflicted for Benefit of Tocilizumab in COVID - 19
One trial shows reduction in mortality, but no evidence of efficacy seen in two additional trials
Source: Pulmonary Medicine News - Doctors Lounge - Category: Respiratory Medicine Tags: Infections, Internal Medicine, Critical Care, Nursing, Pharmacy, Pulmonology, Rheumatology, Journal, Source Type: news
More News: Actemra | COVID-19 | Internal Medicine | Nurses | Nursing | Respiratory Medicine | Rheumatology